ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2014 Financial Results
1/24/2014 6:54:09 AM
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, January 31, 2014, to discuss ImmunoGen's financial results for the three-month period ended December 31, 2013. Management also will provide an update on the Company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by